BC, AOCNP, explains how ctDNA can inform prognosis, monitor disease progression, and guide treatment decisions in oncology.
Abstract: Circulating tumor cell detection is crucial for the early diagnosis and treatment evaluation of cancer. Traditional cell detection methods based on bulky instrumentation, while accurate, ...
Circulating tumor cells (CTCs) are malignant cells that have detached from primary or metastatic tumor sites and entered the peripheral bloodstream. As a critical component of liquid biopsy, the ...
SYDNEY, Sept. 11, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced new findings from a collaborative research program led ...
1 Department of Prevention & Healthcare, The First Affiliated Hospital, Army Medical University, Chongqing, China 2 Department of Information, The First Affiliated Hospital, Army Medical University, ...
A new technique has measured boron in individual cancer cells for the first time, enabling researchers to better understand how drugs act to kill tumors in some cancers. In an article in the Journal ...
A new technique has measured boron in individual cancer cells for the first time, enabling researchers to better understand how drugs act to kill tumours in some cancers. In a new article in the ...
Background: HER2 overexpression predicts the response to trastuzumab in gastric cancer (GC); however, assessing this overexpression requires invasive immunohistochemistry. Circulating tumor cells ...
Bispecific Antibodies in Hematologic and Solid Tumors: Current Landscape and Therapeutic Advances Liquid biopsy encompasses a variety of molecular approaches to detect circulating tumor DNA (ctDNA) ...
1Department of Medical Oncology, Gustave Roussy, Paris-Saclay University, Villejuif, 94805, France. 2Laboratory of Immunomonitoring in Oncology, CNRS UMS 3655, INSERM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback